rs17039365

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001303052.2(MYT1L):​c.-420-20479A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.173 in 152,204 control chromosomes in the GnomAD database, including 2,464 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2464 hom., cov: 32)

Consequence

MYT1L
NM_001303052.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -3.39

Publications

4 publications found
Variant links:
Genes affected
MYT1L (HGNC:7623): (myelin transcription factor 1 like) This gene encodes a member of the zinc finger superfamily of transcription factors whose expression, thus far, has been found only in neuronal tissues. The encoded protein belongs to a novel class of cystein-cystein-histidine-cystein zinc finger proteins that function in the developing mammalian central nervous system. Forced expression of this gene in combination with the basic helix-loop-helix transcription factor NeuroD1 and the transcription factors POU class 3 homeobox 2 and achaete-scute family basic helix-loop-helix transcription factor 1 can convert fetal and postnatal human fibroblasts into induced neuronal cells, which are able to generate action potentials. Mutations in this gene have been associated with an autosomal dominant form of cognitive disability and with autism spectrum disorder. Alternative splicing results in multiple variants. [provided by RefSeq, Jul 2017]
MYT1L Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 39
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • syndromic complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.252 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001303052.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYT1L
NM_001303052.2
MANE Select
c.-420-20479A>G
intron
N/ANP_001289981.1Q9UL68-1
MYT1L
NM_001329844.2
c.-420-20479A>G
intron
N/ANP_001316773.1Q9UL68-1
MYT1L
NM_001329845.1
c.-420-20479A>G
intron
N/ANP_001316774.1Q9UL68-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYT1L
ENST00000647738.2
MANE Select
c.-420-20479A>G
intron
N/AENSP00000497479.2Q9UL68-1
MYT1L
ENST00000428368.7
TSL:1
c.-420-20479A>G
intron
N/AENSP00000396103.3Q9UL68-1
MYT1L
ENST00000399161.8
TSL:1
c.-420-20479A>G
intron
N/AENSP00000382114.3Q9UL68-4

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26315
AN:
152086
Hom.:
2448
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.255
Gnomad AMI
AF:
0.215
Gnomad AMR
AF:
0.136
Gnomad ASJ
AF:
0.103
Gnomad EAS
AF:
0.127
Gnomad SAS
AF:
0.0785
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.108
Gnomad NFE
AF:
0.152
Gnomad OTH
AF:
0.152
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.173
AC:
26371
AN:
152204
Hom.:
2464
Cov.:
32
AF XY:
0.170
AC XY:
12622
AN XY:
74432
show subpopulations
African (AFR)
AF:
0.256
AC:
10619
AN:
41528
American (AMR)
AF:
0.136
AC:
2085
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.103
AC:
356
AN:
3472
East Asian (EAS)
AF:
0.127
AC:
659
AN:
5174
South Asian (SAS)
AF:
0.0785
AC:
378
AN:
4814
European-Finnish (FIN)
AF:
0.130
AC:
1383
AN:
10616
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.152
AC:
10346
AN:
68004
Other (OTH)
AF:
0.150
AC:
316
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1125
2250
3376
4501
5626
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.157
Hom.:
8373
Bravo
AF:
0.180
Asia WGS
AF:
0.102
AC:
353
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.046
DANN
Benign
0.35
PhyloP100
-3.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17039365; hg19: chr2-2197239; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.